Effect of MP-AzeFlu in IL-1 beta-induced IL-6 and proinflammatory cytokines
Immunol Res
.
2023 Jun;71(3):488-496.
doi: 10.1007/s12026-022-09341-5.
Epub 2022 Dec 2.
Authors
Sònia Vicens-Artés
1
,
Jordi Roca-Ferrer
1
2
,
Valeria Tubita
1
3
,
Mireya Fuentes
1
2
,
Isam Alobid
1
2
3
4
,
Antonio Valero
1
2
5
,
Ferdinand Kopietz
6
7
,
DucTung Nguyen
6
,
Joaquim Mullol
8
9
10
11
Affiliations
1
Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, Barcelona, Catalonia, Spain.
2
CIBER of Respiratory Diseases (CIBERES), Barcelona, Catalonia, Spain.
3
Universitat de Barcelona, Barcelona, Catalonia, Spain.
4
Rhinology Unit & Smell Clinic, ENT Department, Hospital Clinic Barcelona, Barcelona, Catalonia, Spain.
5
Allergy Section, Pulmonology & Allergy Department, Barcelona, Catalonia, Spain.
6
MEDA Pharma GmbH & Co. KG (A Mylan Company), Barcelona, Catalonia, Spain.
7
MEDA Pharma GmbH & Co. KG (A Mylan Company), Bad Homburg, Germany.
8
Clinical and Experimental Respiratory Immunoallergy, IDIBAPS, Barcelona, Catalonia, Spain. jmullol@clinic.cat.
9
CIBER of Respiratory Diseases (CIBERES), Barcelona, Catalonia, Spain. jmullol@clinic.cat.
10
Universitat de Barcelona, Barcelona, Catalonia, Spain. jmullol@clinic.cat.
11
Rhinology Unit & Smell Clinic, ENT Department, Hospital Clinic Barcelona, Barcelona, Catalonia, Spain. jmullol@clinic.cat.
PMID:
36456719
DOI:
10.1007/s12026-022-09341-5
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Cytokines
Humans
Interleukin-1beta
Interleukin-6*
Rhinitis, Allergic*
Substances
Interleukin-6
Interleukin-1beta
Cytokines